[Federal Register Volume 87, Number 115 (Wednesday, June 15, 2022)]
[Notices]
[Page 36133]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12850]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
India Council of Medical Research (IMCR) and ICMR Institutions: 
National Institute of Virology (NIV), Pune and National Institute of 
Epidemiology (NIE), Chennai

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces 
three (3) separate awards within the government of India to include the 
Indian Council of Medical Research (ICMR) New Delhi, National Institute 
of Virology (NIV) and National Institute of Epidemiology (NIE). For 
ICMR New Delhi, the award is for approximately $8,165,0000 with an 
expected total funding of approximately $24,495,000. For NIV, the award 
is for approximately $8,165,0000 with an expected total funding of 
approximately $24,495,000. For NIE, the award is for approximately 
$8,165,0000 with an expected total funding of approximately 
$24,495,000. The total 5-year period amount for the three recipients is 
$122,475,000. The awards will accelerate progress toward an India safe 
and secure from infectious disease threats through ICMR institutions' 
focus on emerging and re-emerging pathogens, including detecting, and 
controlling zoonotic disease outbreaks through a One Health approach; 
evaluating vaccine safety monitoring systems; capacitating the public 
health workforce in field epidemiology and outbreak response; and 
combating antimicrobial resistance.

DATES: The period for these awards will be September 30, 2022, through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Shana Eatman, Centers for Disease 
Control and Prevention, 1825 Century Center, MS V18-3, Atlanta, GA 
30345, Telephone: 770-488-3933, E-Mail: [email protected].

SUPPLEMENTARY INFORMATION: The single-source awards will continue 
support to strengthening cooperation with and capacity of the India 
Council of Medical Research (ICMR) institutions to prevent avoidable 
epidemics, early detection of disease threats, and rapid and effective 
response.
    India Council of Medical Research is in a unique position to 
conduct this work, as it was originally established as an apex body for 
the formulation, coordination, and promotion of biomedical research in 
India, and has taken up most of the laboratory-based surveillance of 
infectious diseases in recent years. Eligibility for funding is limited 
to the ICMR, New Delhi and ICMR institutions including the National 
Institute of Virology (NIV), Pune and the National Institute of 
Epidemiology (NIE), Chennai. ICMR is the apex governing body for the 
numerous national level institutes which are centres for excellence and 
reference in specific scientific area for India, namely National 
Institute of Virology, National Institute of Epidemiology, and several 
others. These institutions are mandated by the Ministry of Health of 
Family Health and Welfare (MoHFW) to provide oversight for laboratory 
confirmation of priority pathogens in India in a tiered manner as well 
as collate and analyze surveillance data for public health actions and 
work closely with the state governments where these institutes are 
located.

Summary of the Award

    Recipient: India Council of Medical Research (IMCR), New Delhi and 
ICMR institutions: National Institute of Virology (NIV), Pune and 
National Institute of Epidemiology (NIE), Chennai.
    Purpose of the Award: The purpose of these awards is to accelerate 
progress toward an India safe and secure from infectious disease 
threats through ICMR institutions' focus on emerging and re-emerging 
pathogens, including detecting, and controlling zoonotic disease 
outbreaks through a One Health approach; evaluating vaccine safety 
monitoring systems; capacitating the public health workforce in field 
epidemiology and outbreak response; and combating antimicrobial 
resistance. These GHS strategies will result in outcomes that will 
strengthen the Indian public health system; decrease morbidity and 
mortality; and improve pandemic and epidemic preparedness and response.
    Amount of Award: $8,165,000 in Federal Fiscal Year (FFY) 2022 funds 
per institution, with a total estimated $122,475,0000 for the 5-year 
period of performance, subject to availability of funds. Please note, 
the NOFO funding strategy is as follows: $660,000 for Core Component 1, 
and $7,505,000 in Approved but Unfunded (ABU) Components for each 
recipient.
    Authority: This program is authorized under Section 307 of the 
Public Health Service Act [42 U.S.C. 242I] and Section 301(a) [42 
U.S.C. 241(a)] of the Public Health Service Act.
    Period of Performance: September 30, 2022, through September 29, 
2027.

    Dated: June 9, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-12850 Filed 6-14-22; 8:45 am]
BILLING CODE 4163-18-P